S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

Fennec Pharmaceuticals News Headlines (NASDAQ:FENC)

$8.06
+0.11 (+1.38 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$7.64
Now: $8.06
$8.20
50-Day Range
$6.11
MA: $6.69
$8.06
52-Week Range
$3.26
Now: $8.06
$8.40
Volume71,944 shs
Average Volume58,898 shs
Market Capitalization$160.36 million
P/E RatioN/A
Dividend YieldN/A
Beta0.1

Headlines

Fennec Pharmaceuticals (NASDAQ FENC) News Headlines

Source:
DateHeadline
Fennec Pharmaceuticals: Market Fatigue Due To A Lack Of Catalysts Has Created A Mispricing - Behind The IdeaFennec Pharmaceuticals: Market Fatigue Due To A Lack Of Catalysts Has Created A Mispricing - Behind The Idea
seekingalpha.com - February 19 at 1:10 PM
HC Wainwright Reiterates Buy Rating for Fennec Pharmaceuticals (NASDAQ:FENC)HC Wainwright Reiterates Buy Rating for Fennec Pharmaceuticals (NASDAQ:FENC)
www.americanbankingnews.com - February 18 at 7:43 AM
Fennec Pharmaceuticals (NASDAQ:FENC) Releases Quarterly  Earnings Results, Misses Estimates By $0.05 EPSFennec Pharmaceuticals (NASDAQ:FENC) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - February 16 at 12:52 AM
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Short Interest UpdateFennec Pharmaceuticals Inc (NASDAQ:FENC) Short Interest Update
www.americanbankingnews.com - February 15 at 1:30 AM
Fennec Provides Business Update and Announces Fiscal Year 2019 Financial ResultsFennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
finance.yahoo.com - February 14 at 8:54 AM
Q2 2020 Earnings Estimate for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By WedbushQ2 2020 Earnings Estimate for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By Wedbush
www.americanbankingnews.com - February 14 at 8:36 AM
Wedbush Comments on Fennec Pharmaceuticals Incs FY2024 Earnings (NASDAQ:FENC)Wedbush Comments on Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)
www.americanbankingnews.com - February 13 at 12:15 PM
 Analysts Anticipate Fennec Pharmaceuticals Inc (NASDAQ:FENC) Will Post Earnings of -$0.13 Per Share Analysts Anticipate Fennec Pharmaceuticals Inc (NASDAQ:FENC) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - February 13 at 5:38 AM
Fennec Pharmaceuticals (FENC) "Buy" Rating Reiterated at HC WainwrightFennec Pharmaceuticals' (FENC) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - February 12 at 7:05 AM
Fennec Pharma completes NDA submission for PedmarkFennec Pharma completes NDA submission for Pedmark
seekingalpha.com - February 11 at 8:14 AM
Fennec Pharmaceuticals: Time Is TickingFennec Pharmaceuticals: Time Is Ticking
seekingalpha.com - February 10 at 7:07 PM
Short Interest in Fennec Pharmaceuticals Inc (NASDAQ:FENC) Rises By 10.4%Short Interest in Fennec Pharmaceuticals Inc (NASDAQ:FENC) Rises By 10.4%
www.americanbankingnews.com - January 29 at 10:50 PM
3 Healthcare Stocks That Can Double This Year3 Healthcare Stocks That Can Double This Year
finance.yahoo.com - January 29 at 12:56 PM
Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?
finance.yahoo.com - November 27 at 12:41 PM
BRIEF-Fennec Pharmaceuticals Inc Qtrly Loss Per Share $0.09BRIEF-Fennec Pharmaceuticals Inc Qtrly Loss Per Share $0.09
www.msn.com - November 12 at 11:49 PM
Fennec Pharmaceuticals EPS beats by $0.11Fennec Pharmaceuticals EPS beats by $0.11
seekingalpha.com - November 12 at 8:47 AM
Fennec Provides Business Update and Announces Third Quarter 2019 Financial ResultsFennec Provides Business Update and Announces Third Quarter 2019 Financial Results
finance.yahoo.com - November 12 at 8:47 AM
Fennec Pharmaceuticals Inc.Fennec Pharmaceuticals Inc.
www.barrons.com - October 31 at 10:32 PM
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Are In A Position To Invest In GrowthCompanies Like Fennec Pharmaceuticals (NASDAQ:FENC) Are In A Position To Invest In Growth
finance.yahoo.com - October 17 at 5:13 PM
Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
finance.yahoo.com - October 2 at 7:41 AM
Fennec Appoints Jodi A. Cook, PhD to Its Board of DirectorsFennec Appoints Jodi A. Cook, PhD to Its Board of Directors
finance.yahoo.com - September 24 at 7:18 AM
Fennec Appoints Shubh Goel as Chief Commercial OfficerFennec Appoints Shubh Goel as Chief Commercial Officer
finance.yahoo.com - September 9 at 8:26 AM
Fennec Pharmaceuticals EPS misses by $0.10Fennec Pharmaceuticals EPS misses by $0.10
seekingalpha.com - August 9 at 9:11 AM
Fennec Provides Business Update and Announces Second Quarter 2019 Financial ResultsFennec Provides Business Update and Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 9 at 9:11 AM
Fennec Pharmaceuticals (NASDAQ:FENC) Shareholders Have Enjoyed A 76% Share Price GainFennec Pharmaceuticals (NASDAQ:FENC) Shareholders Have Enjoyed A 76% Share Price Gain
finance.yahoo.com - July 19 at 4:42 PM
Fennec Provides Business Update and Announces First Quarter 2019 Financial ResultsFennec Provides Business Update and Announces First Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 9:45 AM
This $90M public company is "set up" for sale, CFO saysThis $90M public company is "set up" for sale, CFO says
www.bizjournals.com - April 25 at 5:53 PM
This $90M NC public company is "set up" for sale, CFO saysThis $90M NC public company is "set up" for sale, CFO says
www.bizjournals.com - April 25 at 5:53 PM
This $90M public company is "set up" for sale, CFO saysThis $90M public company is "set up" for sale, CFO says
finance.yahoo.com - April 25 at 5:53 PM
With stock down 68% in past year, RTP outfit's CEO, CFO enjoy 15% bump in compensationWith stock down 68% in past year, RTP outfit's CEO, CFO enjoy 15% bump in compensation
finance.yahoo.com - April 24 at 5:24 PM
When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Turn A Profit?When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Turn A Profit?
finance.yahoo.com - April 4 at 6:17 PM
Fennec Pharma down 9% on Pedmark filing delayFennec Pharma down 9% on Pedmark filing delay
seekingalpha.com - March 13 at 5:42 PM
Fennec Provides Business Update and Announces Fiscal Year 2018 Financial ResultsFennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
finance.yahoo.com - March 13 at 8:49 AM
Fennec Pharma Secures Loan In Preparation For Pedmark MarketizationFennec Pharma Secures Loan In Preparation For Pedmark Marketization
seekingalpha.com - March 8 at 6:09 PM
Post-FDA Meeting, The Path Ahead Of Fennec Is ClearPost-FDA Meeting, The Path Ahead Of Fennec Is Clear
seekingalpha.com - January 9 at 9:51 AM
Do Institutions Own Shares In Fennec Pharmaceuticals Inc. (NASDAQ:FENC)?Do Institutions Own Shares In Fennec Pharmaceuticals Inc. (NASDAQ:FENC)?
finance.yahoo.com - December 25 at 4:23 PM
Fennec Pharmaceuticals: SIOP 2018 Provides Insight Into Pedmark TrajectoryFennec Pharmaceuticals: SIOP 2018 Provides Insight Into Pedmark Trajectory
seekingalpha.com - December 21 at 9:32 AM
Fennec Pharmaceuticals: SIOP 18 Provides Insight Into Pedmark TrajectoryFennec Pharmaceuticals: SIOP '18 Provides Insight Into Pedmark Trajectory
seekingalpha.com - December 20 at 4:38 PM
Fennec Pharma Initiates Rolling NDA For PEDMARKTM - Quick FactsFennec Pharma Initiates Rolling NDA For PEDMARKTM - Quick Facts
www.nasdaq.com - December 20 at 9:43 AM
Fennec Pharmaceuticals initiates NDA for PEDMARKFennec Pharmaceuticals initiates NDA for PEDMARK
seekingalpha.com - December 20 at 9:43 AM
Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Administration for PEDMARK™Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Administration for PEDMARK™
finance.yahoo.com - December 20 at 9:43 AM
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel